Hardik Desai Family Trust Discloses Share Acquisition in Trident Lifeline Limited

1 min read     Updated on 16 Mar 2026, 07:53 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Hardik Desai Family Trust acquired 4,200 shares of Trident Lifeline Limited through open market transactions on 12.03.2026, increasing its holding from 8,38,766 to 8,42,966 shares. This acquisition raised the trust's ownership stake from 7.03% to 7.06% of the total share capital. The disclosure was filed under SEBI regulations, with the trust maintaining its status as a promoter group entity in the company.

powered bylight_fuzz_icon
35216594

*this image is generated using AI for illustrative purposes only.

Hardik Desai Family Trust has submitted a regulatory disclosure to BSE Limited regarding its recent acquisition of shares in Trident Lifeline Limited . The disclosure, filed in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, details the trust's increased shareholding in the company.

The trust, operating through its Ultimate Beneficial Owner (UBO) Hardik Jigishkumar Desai, is categorized as a promoter group entity. Desai is based in Surat, Gujarat, and serves as the trustee of the family trust.

Share Acquisition Details

The transaction involved the acquisition of 4,200 equity shares through open market purchases on 12.03.2026. This acquisition represents a modest increase in the trust's shareholding position.

Parameter: Before Acquisition After Acquisition Change
Number of Shares: 8,38,766 8,42,966 +4,200
Percentage of Total Share Capital: 7.03% 7.06% +0.03%
Percentage of Diluted Capital: 6.72% 6.75% +0.03%

Company Capital Structure

Trident Lifeline Limited's equity share capital remained unchanged following the transaction. The company maintains an equity share capital structure as detailed below:

Capital Type: Amount Number of Shares
Equity Share Capital: Rs. 11,93,30,000 1,19,33,000 shares of Rs. 10 each
Total Diluted Capital: Rs. 12,49,34,000 1,24,93,400 shares of Rs. 10 each

The diluted share capital accounts for the potential conversion of outstanding convertible securities and warrants into equity shares.

Regulatory Compliance

The disclosure was filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The trust confirmed that it holds no encumbered shares, voting rights other than through shares, or convertible instruments that would entitle it to additional voting rights in the company.

The transaction represents a routine open market acquisition by a promoter group entity, maintaining transparency in shareholding changes as required by regulatory frameworks. Trident Lifeline Limited's shares are listed on BSE Limited under scrip code 543616.

Historical Stock Returns for Trident Lifeline

1 Day5 Days1 Month6 Months1 Year5 Years
+7.83%+7.30%+2.52%-9.73%-0.56%+144.57%

Trident Lifeline's Shareholding in Subsidiary Trident Mediquip Reduces to 57.34% After Private Placement

1 min read     Updated on 03 Mar 2026, 04:06 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Trident Lifeline Limited's shareholding in subsidiary Trident Mediquip Limited has decreased from 60.04% to 57.34% following a private placement of equity shares to other shareholders. Trident Mediquip, incorporated in 2019, operates in the pharmaceuticals and chemical industry with a current turnover of 21.29 crores and paid-up share capital of Rs. 9.78 crores. The transaction has been disclosed under SEBI regulations as a related party transaction conducted on an arm's length basis.

powered bylight_fuzz_icon
34079818

*this image is generated using AI for illustrative purposes only.

Trident Lifeline Limited has reported a reduction in its shareholding in subsidiary Trident Mediquip Limited following a private placement transaction. The company's stake in the subsidiary has decreased from 60.04% to 57.34% after Trident Mediquip Limited allotted equity shares to other shareholders.

Shareholding Change Details

The change in shareholding occurred due to a private placement of equity shares by Trident Mediquip Limited to other shareholders. This transaction has resulted in a dilution of Trident Lifeline's ownership stake in its subsidiary.

Parameter: Details
Pre-holding: 60.04%
Post-holding: 57.34%
Transaction Type: Private Placement
Regulatory Filing: Under Regulation 30 of SEBI (LODR)

About Trident Mediquip Limited

Trident Mediquip Limited is a subsidiary company incorporated under the Companies Act, 2013, with its registered office in Surat, Gujarat. The company operates in the pharmaceuticals and chemical industry and was incorporated on October 19, 2019.

Financial Structure

Financial Parameter: Amount
Authorized Share Capital: Rs. 10.00 crores
Paid-up Share Capital: Rs. 9.78 crores
Number of Equity Shares: 97,75,800 shares
Face Value per Share: Rs. 10
Current Turnover: 21.29 crores

Historical Performance

Trident Mediquip Limited's turnover performance over the last three financial years shows:

Financial Year: Turnover
2022-23: 28.77 crores
2023-24: 20.58 crores
2024-25: 21.29 crores

Related Party Transaction

The transaction qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. The filing indicates that several promoters and directors of Trident Lifeline Limited, including Mr. Amit Bhupendra Halvawala, Mr. Chetan Chandrakant Jariwala, and Mr. Hardik Jigishkumar Desai, have interests in the subsidiary. The company has confirmed that the transaction is being undertaken on an arm's length basis.

Regulatory Compliance

Trident Lifeline Limited has filed the necessary disclosures under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also complied with SEBI Master Circular requirements in making this announcement to the stock exchanges.

Historical Stock Returns for Trident Lifeline

1 Day5 Days1 Month6 Months1 Year5 Years
+7.83%+7.30%+2.52%-9.73%-0.56%+144.57%

More News on Trident Lifeline

1 Year Returns:-0.56%